Print Page  Close Window

SEC Filings

OREXIGEN THERAPEUTICS, INC. filed this Form S-1/A on 04/09/2007
Entire Document

  (c)   COLLABORATION JOINT INTELLECTUAL PROPERTY. CYPRESS will have the first right, using in-house or outside legal counsel selected by CYPRESS at its sole discretion, to prepare, file, prosecute, maintain and extend patent applications and patents included in the COLLABORATION JOINT INTELLECTUAL PROPERTY in countries selected by mutual agreement of CYPRESS and OREXIGEN. OREXIGEN and CYPRESS will equally bear all costs relating to such activities. CYPRESS will solicit OREXIGEN’s advice and review of such patent applications and all substantive prosecution actions, and CYPRESS will take into consideration OREXIGEN’s advice thereon. If CYPRESS elects not to prepare, file, prosecute or maintain certain of such patent applications or patents or certain claims encompassed within such patent applications or patents, in one or more countries, CYPRESS will give OREXIGEN notice thereof within a reasonable period prior to allowing such patent applications, patents or claims to lapse or become abandoned or unenforceable, and OREXIGEN will thereafter have the right, at its sole expense and discretion, to prepare, file, prosecute and maintain such patent applications and patents in such one or more countries and furthermore, CYPRESS shall take all actions to have such rights assigned to OREXIGEN.
  6.02   COOPERATION. Each party agrees to cooperate fully in the preparation, fling, prosecution and maintenance of any patent applications and patents under this AGREEMENT. Such cooperation includes, but is not limited to:
  (a)   executing all papers and instruments, or requiring its AGENTS to execute such papers and instruments, so as to effectuate the ownership of COLLABORATION INTELLECTUAL PROPERTY set forth in Section 6.01 and to enable the other party to apply for and to prosecute patent applications in any country; and
  (b)   promptly informing the other party of any matters coming to such party’s attention that may affect the preparation, filing, or prosecution of any such patent applications.
  6.03   PATENT TERM RESTORATION. The parties hereto shall cooperate with each other in obtaining patent term restoration or supplemental protection certificates or their equivalents in any country where applicable to patents included within the OREXIGEN PATENT RIGHTS under this AGREEMENT.
  6.04   MARKING OF LICENSED PRODUCTS. CYPRESS agrees to mark the LICENSED PRODUCTS (as the case may be), and/or their containers, labels, and/or other packaging, in such a manner as to conform to the patent laws and practices of the country of manufacture or sale, as appropriate.

- 18 -